Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease.

David H SmithSusan ShetterlyJames FloryKevin HaynesChristine Y LuJoshua J GagneLisa HerrintonCarsie NyirendaElisabetta PatornoAzadeh ShoaibiMarsha A Raebel

Published in: Pharmacoepidemiology and drug safety (2018)

We suggest that drug safety researchers consider whether the method of cohort identification contributes to generalizability of safety findings.

Keyphrases

chronic kidney disease
end stage renal disease
electronic health record
big data
machine learning
soft tissue
deep learning
artificial intelligence